tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
RESEARCH TOOLSreports

Aquestive Therapeutics (AQST) Cash flow

2,470 Followers

Aquestive Therapeutics Cash Flow

AQST's free cash flow for Q4 2025 was $-8.55M. For the 2025 fiscal year, AQST's free cash flow was decreased by $-17.08M and operating cash flow was $-8.47M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -52.43M$ -35.76M$ -6.38M$ -9.79M$ -32.98M
Investing Cash Flow
$ -562.00K$ -159.00K$ -995.00K$ -2.52M$ -913.00K
Financing Cash Flow
$ 102.62M$ 83.59M$ 3.97M$ 11.56M$ 30.11M
End Cash Position
$ 121.17M$ 71.55M$ 23.87M$ 27.27M$ 28.02M
Free Cash Flow
$ -52.99M$ -35.92M$ -7.38M$ -12.31M$ -33.89M
Currency in USD

Aquestive Therapeutics Cash Flow